Targocid for Serious gram-positive infections

Quick answer: Targocid is used for Serious gram-positive infections as part of a glycopeptide antibiotic treatment regimen. Inhibits bacterial cell wall synthesis by binding to D-alanyl-D-alanine peptidoglycan precursors The specific dosing for Serious gram-positive infections is determined by your prescriber based on individual factors.

Why is Targocid used for Serious gram-positive infections?

Targocid belongs to the Glycopeptide antibiotic class. Inhibits bacterial cell wall synthesis by binding to D-alanyl-D-alanine peptidoglycan precursors This action makes it useful for treating or managing Serious gram-positive infections in patients for whom this approach is clinically appropriate.

It is one of several treatment options. Whether Targocid is the right choice for a specific patient depends on the type and severity of Serious gram-positive infections, response to previous treatments, individual risk factors, and clinical guidelines.

Typical dosing for Serious gram-positive infections

Common adult dosing range: 400 mg IV/IM once daily after loading. The actual dose for Serious gram-positive infections depends on:

For complete dosing details, see the Targocid medicine page.

What to expect

Targocid treatment for Serious gram-positive infections typically involves:

Alternatives to consider

If Targocid is not appropriate or not tolerated, alternatives within the same class or different therapeutic classes may be considered. See all Glycopeptide antibiotic for related options.

When to talk to your doctor

Discuss with your prescriber if you experience:

Related information

Targocid full prescribing information ยท All Glycopeptide antibiotic alternatives

Medical disclaimer: This tool provides educational information for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your individual situation with a qualified healthcare provider.

Frequently asked questions

How effective is Targocid for Serious gram-positive infections?

Effectiveness varies by individual response, dose, and severity. Targocid is one of several treatment options for Serious gram-positive infections, supported by clinical evidence within the glycopeptide antibiotic class. Discuss expected response with your prescriber.

How long do I need to take Targocid for Serious gram-positive infections?

Treatment duration depends on the nature of Serious gram-positive infections โ€” some treatments are short-term, others long-term or lifelong. Never stop on your own; discontinuation requires clinical guidance to avoid relapse or rebound effects.

What are the main side effects of Targocid when used for Serious gram-positive infections?

Common and serious side effects are class-related and substance-specific. See the full medicine page for the complete profile. Report any unexpected effects to your prescriber.

Are there alternatives to Targocid for Serious gram-positive infections?

Yes. Multiple medicines and non-drug options exist for Serious gram-positive infections. Alternatives within the glycopeptide antibiotic class share mechanisms; other classes may offer different approaches. Discuss with your clinician.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.